Transcriptomic analysis of effects of cancer cell detachment after treatment with 2-deoxy-D-glucose alone or in co-treatment with metformin
RNA-seq (gene expression) · human · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 30 samples: 10 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- MDA-MB-231 breast cancer cells adapted to anchorage-independent growth reveal senescent-like phenotype and persistent downregulation of PD-L1 expressionFrontiers in oncology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE279580_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1173549 and SRA study SRP538891. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 29 samples.
How we read this: 10 replicated groups read from 30 sample titles; they account for 29 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8576357 ctrl, selected, rep 1 ctrl, selected,
- GSM8576358 ctrl, selected, rep 2 ctrl, selected,
- GSM8576359 ctrl, selected, rep 3 ctrl, selected,
- GSM8576360 4.8 mM 2DG, selected, rep 1 4.8 mM 2DG, selected,
- GSM8576361 4.8 mM 2DG, selected, rep 2 4.8 mM 2DG, selected,
- GSM8576362 4.8 mM 2DG, selected, rep 3 4.8 mM 2DG, selected,
- GSM8576363 5 mM meftormin + 0.6 mM 2DG, selected, rep 1 5 mM meftormin + 0.6 mM…
- GSM8576364 5 mM meftormin + 0.6 mM 2DG, selected, rep 2 5 mM meftormin + 0.6 mM…
- GSM8576365 5 mM meftormin + 0.6 mM 2DG, selected, rep 3 5 mM meftormin + 0.6 mM…
- GSM8576366 polyHEMA, selected, rep 1 polyHEMA, selected,
- GSM8576367 polyHEMA, selected, rep 2 polyHEMA, selected,
- GSM8576368 polyHEMA, selected, rep 3 polyHEMA, selected,
- GSM8576369 ctrl, rep 1 ctrl,
- GSM8576370 ctrl, rep 2 ctrl,
- GSM8576371 ctrl, rep 3 ctrl,
- GSM8576372 4.8 mM 2DG, attached, rep 1 4.8 mM 2DG, attached,
- GSM8576373 4.8 mM 2DG, attached, rep 2 4.8 mM 2DG, attached,
- GSM8576374 4.8 mM 2DG, attached, rep 3 4.8 mM 2DG, attached,
- GSM8576375 4.8 mM 2DG, dettached, rep 1 4.8 mM 2DG, dettached,
- GSM8576376 4.8 mM 2DG, dettached, rep 2 4.8 mM 2DG, dettached,
- GSM8576377 4.8 mM 2DG, dettached, rep 3 4.8 mM 2DG, dettached,
- GSM8576378 5 mM meftormin + 0.6 mM 2DG, attached, rep 1 5 mM meftormin + 0.6 mM…
- GSM8576379 5 mM meftormin + 0.6 mM 2DG, attached, rep 2 5 mM meftormin + 0.6 mM…
- GSM8576380 5 mM meftormin + 0.6 mM 2DG, attached, rep 3 5 mM meftormin + 0.6 mM…
- GSM8576381 5 mM meftormin + 0.6 mM 2DG, dettached, rep 1 5 mM meftormin + 0.6 mM…
- GSM8576382 5 mM meftormin + 0.6 mM 2DG, dettached, rep 2 5 mM meftormin + 0.6 mM…
- GSM8576383 5 mM meftormin + 0.6 mM 2DG, dettached, rep 3 5 mM meftormin + 0.6 mM…
- GSM8576384 polyHEMA, rep 1 polyHEMA,
- GSM8576385 polyHEMA, rep 2 polyHEMA,
- GSM8576386 polyHEMA rep 3
- GSE289713 Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations 11 samples shares co-treatment, treatment
- GSE283522 The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer 1254 samples shares treatment
- GSE319641 RNA-Seq profiling of pre- and on-treatment tumor samples from breast cancer patients enrolled in the NeoTRIP trial. 401 samples shares treatment
- GSE222196 Treatment of prostate cancer cell lines with Androgen Receptor and Receptor Tyrosine Kinase inhibitors 246 samples shares treatment
- GSE245851 Transcriptomic analysis of human gastric cancer cell lines following T-DXd treatment 15 samples shares treatment
- GSE330465 Gene expression profiling of neoadjuvant ABFOLFOX treatment in patients with unresectable colorectal cancer with liver metastases 104 samples shares treatment
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares treatment
- GSE330358 CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer 36 samples shares treatment
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.